Total Payments
$5,817
2024 Payments
$1,958
Companies
23
Transactions
105
Medicare Patients
2,266
Medicare Billing
$292,180
Payment Breakdown by Category
Food & Beverage$5,817 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,817 | 105 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $911.04 | 16 | $0 (2024) |
| Allergan, Inc. | $792.51 | 12 | $0 (2021) |
| Genentech USA, Inc. | $605.60 | 6 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $536.49 | 5 | $0 (2024) |
| ABBVIE INC. | $468.19 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $387.78 | 4 | $0 (2024) |
| Alcon Vision LLC | $341.13 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $307.45 | 15 | $0 (2022) |
| Harrow Eye, LLC | $259.12 | 2 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $217.62 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,958 | 32 | Bausch & Lomb Americas Inc. ($426.46) |
| 2023 | $1,080 | 13 | Genentech USA, Inc. ($300.00) |
| 2022 | $1,064 | 20 | Genentech USA, Inc. ($305.60) |
| 2021 | $215.00 | 8 | Allergan, Inc. ($126.08) |
| 2020 | $256.24 | 4 | Allergan, Inc. ($130.90) |
| 2019 | $789.28 | 20 | Allergan Inc. ($404.86) |
| 2018 | $200.31 | 6 | Allergan Inc. ($130.67) |
| 2017 | $254.09 | 2 | Sun Pharmaceutical Industries Inc. ($254.09) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: EYE CARE | ||||||
| 12/12/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: EYE CARE | ||||||
| 12/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Dry eyes | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $134.12 | General |
| Category: OPTOMETRY | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $132.46 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: EYE CARE | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $128.81 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Dry eyes | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $39.62 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Dry eyes | ||||||
| 10/10/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPTOMETRY | ||||||
| 10/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $143.73 | General |
| Category: Ophthalmology | ||||||
| 10/03/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: EYE CARE | ||||||
| 07/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/26/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Dry eyes | ||||||
| 06/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $109.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: EYE CARE | ||||||
| 05/27/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $121.96 | General |
| 05/22/2024 | Rayner Intraocular Lenses Limited | Omidria (Drug), RayOne EMV, RayOne Spheric | Food and Beverage | Cash or cash equivalent | $32.33 | General |
| Category: Ophthalmology | ||||||
| 04/23/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Ophthalmology | ||||||
| 04/19/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: SOLUTION/ DROPS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 598 | 1,059 | $184,400 | $62,170 |
| 2022 | 10 | 529 | 965 | $157,785 | $58,340 |
| 2021 | 10 | 596 | 1,105 | $177,705 | $70,739 |
| 2020 | 11 | 543 | 938 | $216,330 | $100,931 |
Total Patients
2,266
Total Services
4,067
Medicare Billing
$292,180
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67028 | Injection of drug into eye | Office | 2023 | 36 | 132 | $42,100 | $13,869 | 32.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 95 | 128 | $27,700 | $12,727 | 45.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 82 | 105 | $17,290 | $8,162 | 47.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 30 | 123 | $18,450 | $6,758 | 36.6% |
| 92134 | Imaging of retina | Office | 2023 | 79 | 193 | $25,400 | $6,746 | 26.6% |
| 92250 | Photography of the retina | Office | 2023 | 100 | 122 | $15,400 | $3,748 | 24.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 37 | 89 | $13,850 | $3,627 | 26.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 25 | 25 | $6,250 | $2,972 | 47.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 23 | 25 | $5,000 | $1,381 | 27.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 34 | 41 | $6,175 | $1,210 | 19.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 57 | 76 | $6,785 | $971.26 | 14.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 103 | 149 | $29,900 | $15,283 | 51.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 38 | 140 | $42,000 | $14,582 | 34.7% |
| 92134 | Imaging of retina | Office | 2022 | 73 | 182 | $22,825 | $6,512 | 28.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 26 | 92 | $13,800 | $4,835 | 35.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 49 | 61 | $8,110 | $4,678 | 57.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 32 | 32 | $8,000 | $3,728 | 46.6% |
| 92250 | Photography of the retina | Office | 2022 | 87 | 118 | $11,800 | $3,502 | 29.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 36 | 82 | $12,350 | $3,334 | 27.0% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 66 | 87 | $6,250 | $1,200 | 19.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 19 | 22 | $2,750 | $685.15 | 24.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 124 | 185 | $36,800 | $20,087 | 54.6% |
| 67028 | Injection of drug into eye | Office | 2021 | 32 | 147 | $44,100 | $15,729 | 35.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 94 | 228 | $28,500 | $8,525 | 29.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 28 | 118 | $17,700 | $6,785 | 38.3% |
About Dr. Raphael Castillo, MD
Dr. Raphael Castillo, MD is a Ophthalmology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770664294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raphael Castillo, MD has received a total of $5,817 in payments from pharmaceutical and medical device companies, with $1,958 received in 2024. These payments were reported across 105 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,817).
As a Medicare-enrolled provider, Castillo has provided services to 2,266 Medicare beneficiaries, totaling 4,067 services with total Medicare billing of $292,180. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location New York, NY
- Active Since 10/18/2006
- Last Updated 10/12/2015
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770664294
Products in Payments
- Cequa (Drug) $593.18
- LUMIGAN (Drug) $544.68
- RESTASIS (Drug) $378.88
- VABYSMO (Drug) $305.60
- Vabysmo (Drug) $300.00
- MIEBO (Drug) $276.19
- VEVYE (Drug) $259.12
- Bromsite (Drug) $254.09
- EYLEA HD (Biological) $241.44
- enVista MX60 IOL (Device) $239.07
- HYDRUS Microstent (Device) $186.51
- VUITY (Drug) $154.09
- Izervay (Drug) $148.74
- EYLEA (Biological) $146.34
- TYRVAYA (Drug) $132.80
- TEPEZZA (Drug) $123.88
- TECNIS IOL (Device) $122.43
- TEPEZZA (Biological) $109.54
- AcrySof IQ PanOptix (Device) $95.35
- Tecnis 1-piece IOL (Device) $76.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in New York
Dr. Tsontcho Ianchulev, M.d. Mph, M.D. MPH
Ophthalmology — Payments: $21.4M
Ophthalmology $21.4M
Dr. Nathan Radcliffe, M.d, M.D
Ophthalmology — Payments: $2.2M
Ophthalmology $2.2M
Dr. Joshua Young, M.d, M.D
Ophthalmology — Payments: $805,605
Ophthalmology $805,605
Dr. Raymond Fong, M.d, M.D
Ophthalmology — Payments: $581,936
Ophthalmology $581,936
Joseph Panarelli, M.d, M.D
Ophthalmology — Payments: $525,201
Ophthalmology $525,201
David Guyer
Ophthalmology — Payments: $491,407
Ophthalmology $491,407